利什曼原虫p27基因敲除减毒活疫苗候选株的免疫保护与效力评价
研究评估了缺失p27基因的利什曼原虫减毒活疫苗(Lmp27-/-)在BALB/c小鼠中的保护性免疫与效力。免疫小鼠在受到利什曼原虫和婴儿利什曼原虫攻击后,表现出显著Th1应答、更小皮肤病变及肝脾虫负荷降低,并产生交叉保护。结果表明Lmp27-/-寄生虫对同源和异源利什曼原虫感染均提供显著保护免疫和效力。
要点
- Lmp27-/-减毒活疫苗在BALB/c小鼠中诱导显著Th1免疫应答。
- 免疫后攻击利什曼原虫,皮肤病变减小、肝脾虫负荷降低。
- Lmp27-/-对婴儿利什曼原虫感染提供交叉保护。
核心结论
- Lmp27-/-寄生虫免疫可对同源及异源利什曼原虫感染提供显著保护免疫和效力。
研究设计与样本
- 在BALB/c小鼠中分别用利什曼原虫和婴儿利什曼原虫攻击,评估Lmp27-/-减毒活疫苗的保护免疫与效力。
主要发现
- 免疫小鼠在利什曼原虫攻击后出现显著Th1应答、更小皮肤病变及肝脾虫负荷降低。
- Lmp27-/-突变株对婴儿利什曼原虫感染提供交叉保护。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Leishmaniasis is a growing health problem in many parts of the world and efforts to find vaccine against the disease are a public health priority. Live attenuated vaccines are the gold standard for protection against intracellular pathogens such as Leishmania spp. Defined genetic alteration of the Leishmania genome can be achieved using a gene-targeted disruption strategy that allows for the selection of parasites lacking genes essential for long-term survival and virulence. Previously, we demonstrated that genetically modified live attenuated Leishmania major, lacking the p27gene (Lmp27-/-) is safe and induces cellular immunity in BALB/c mice. p27 is a component of the COX complex that is responsible for ATP synthesis. In the current study, the Lmp27-/- strain was assessed as a live attenuated vaccine. Overall protective immunity and efficacy were evaluated at various time periods following Leishmania major (L. major) and Leishmania infantum (L. infantum) challenges separately in BALB/c mice. Cytokine and anti-Leishmania antibody levels, splenocyte proliferation, delayed type hypersensitivity (DTH), skin lesion development, and parasite burden in the liver and spleen were the measured variables. The results demonstrated that immunized mice had a significant T-helper type 1 (Th1) response, smaller skin lesions and lower parasite burdens in their liver and spleens following a L. major challenge. Furthermore, the Lmp27-/- mutant also granted cross-protection against L. infantum infection. These results suggest that immunization with Lmp27-/- parasites provide significant protective immunity and efficacy against infection with homologous as well as heterologous species of Leishmania parasites.
引用
- Elikaee S, Mohebali M, Rezaei S, et al. Leishmania major p27 gene knockout as a novel live attenuated vaccine candidate: Protective immunity and efficacy evaluation against cutaneous and visceral leishmaniasis in BALB/c mice. Vaccine. 2019. PMID: 31047672. doi:10.1016/j.vaccine.2019.04.068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。